Position in SGMOQ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$959,166
-$2,581,569 QoQ
Shares Held
3,836,665
-54.5% QoQ
Ownership
0.926%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in SGMOQ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $959,166 | 3,836,665 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,540,735 | 8,430,323 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,822,250 | 10,182,463 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,693,294 | 6,839,434 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,090,950 | 3,168,107 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,146,574 | 3,084,877 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,221,915 | 4,852,777 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,485,567 | 4,126,577 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,740,644 | 2,597,977 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,698,774 | 3,145,878 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,419,452 | 2,365,754 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,987,744 | 3,067,496 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,689,719 | 3,232,795 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,655,217 | 2,119,496 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,163,870 | 1,666,096 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,959,513 | 1,439,496 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,433,587 | 763,096 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,380,220 | 850,696 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,626,855 | 735,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,980,904 | 583,200 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,770,894 | 779,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $20,177,486 | 1,292,600 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $12,525,889 | 1,325,491 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||